SecBot SecBot
SECBOTREPLAY Home › Report › FULC

FULC · Kevin Tang and Tang Capital Management LLC filed a Form 3 initial…

Fulcrum Therapeutics, Inc. · 3 filed Jul 15, 2026 at 19:49 ET

At the news

BULLISHIMPACT 6/10

3 filed Jul 15, 2026 at 19:49 ET

Kevin Tang and Tang Capital Management LLC filed a Form 3 initial statement of beneficial ownership, disclosing a 6,663,383-share stake in Fulcrum Therapeutics. This represents a new, significant position by a known activist investor, suggesting potential strategic engagement at a beaten-down biotech with a $239M market cap and largely negative analyst consensus.

  • Kevin Tang and Tang Capital Management LLC filed Form 3 on 2026-07-15, reporting beneficial ownership of 6,663,383 shares of FULC common stock.
  • The shares are held indirectly through Tang Capital Partners, LP, Tang Capital Partners International, LP, Tang Capital Partners III, Inc., and Tang Capital Partners IV, Inc.
  • Kevin Tang is the sole manager/director/CEO of the reporting entities, giving him control and pecuniary interest in the stake.
  • The filing is an initial statement, indicating a new position by Tang Capital, a known activist investment firm.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access